期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Improved ZiehI-Neelsen Microscopy: Bleach Sputum Smear Negative Specimens after Centrifugation
1
作者 Sophia Wanja Matu Ernest Juma 《Journal of Life Sciences》 2013年第6期607-612,共6页
Background: Direct ZN (Ziehl-Neelsen) sputum smear microscopy for diagnosis of TB (tuberculosis) has low sensitivity, especially in TB/HIV co-infected patients. Sputum concentration by bleach (NaOCI) with sedim... Background: Direct ZN (Ziehl-Neelsen) sputum smear microscopy for diagnosis of TB (tuberculosis) has low sensitivity, especially in TB/HIV co-infected patients. Sputum concentration by bleach (NaOCI) with sedimentation has been used to increase the sensitivity of sputum smear microscopy in many settings but with varying results. Objective: To determine whether bleach plus centrifugation significantly improves the detection of AFB (acid-fast bacilli) in ZN smear-negative sputum specimens. Methods: Three hundred and seventy sputum specimens were collected from new TB suspects attending a Nairobi referral district hospital and processed for direct microscopy using ZN technique and culture on Lowenstein Jensen Media. All smear-negative specimens were treated with 3.5% bleach and left to stand for 30 min before centrifugation. The bleach treated smears were processed and examined using ZN technique. Results: Of the 370 specimens, 200 (54%) were positive culture. The number of sputum samples that were smear-positive by direct ZN was 138 (37.2%), with a sensitivity of 66%. After treatment of direct ZN smear-negative specimens with 3.5% bleach and centrifugation, the total number of AFB smear-positive samples increased to 171 with an increase in sensitivity of 66% to 81.1% (15.1%). Conclusion: In this study, bleach with centrifugation significantly increased the yield of sputum smear microscopy. Further evaluation of these techniques in routine programmes is required especially in settings where the burden of TB/HIV is high. 展开更多
关键词 Diagnosis smear-negative TB CENTRIFUGATION Ziehl-Neelsen microscopy.
下载PDF
4th National Anti-tuberculosis Drug Resistance Survey in Kenya
2
作者 Joseph Sitienei Kamene Kimenye +15 位作者 Josephine Wahogo Bernard Langat Enos Masini Obadiah Njuguna Jane Ong'ang'o Sophie Matu Jeremiah Okari Maurice Maina Margret Mburu Herman Weyenga Jane Mwangi Lucy Nganga Agnes Langat Abraham Katana Hillary Kipruto Joel Kangangi 《Journal of Health Science》 2017年第6期282-291,共10页
Introduction: Recently rapid development of drug resistant TB, particularly MDR TB (Multi Drug Resistant TB) and XDRTB (Extensively Drug-Resistant TB) possess a major threat to control of tuberculosis globally. I... Introduction: Recently rapid development of drug resistant TB, particularly MDR TB (Multi Drug Resistant TB) and XDRTB (Extensively Drug-Resistant TB) possess a major threat to control of tuberculosis globally. Information on the extent of MDR-TB from Kenya is largely limited due to several factors. Monitoring of development of resistance is a vital tool in providing critical information for effective planning for TB control and in management of patients infected with TB. Methods: Cross-sectional with cluster design. Results: A total of 2,171 participants recruited into the study from 50 selected clusters. Prevalence of rifampicin resistance for new cases was 1.3% [95% CI, 0.8-2.0] and INH resistance was 5.5% [95% CI, 4.5-6.7]. MDR TB was found in 0.67% of new cases and 2.1% amongst previously treated TB cases. Discussion: Resistance to isoniazid in Kenya has been on the decline due to introduction of rifampicin in combined therapy. There was increase of MDR TB among new cases by 24% and decline in previously treated cases due to lethal impact of HIV. Conclusions: Although drug resistance TB is a growing problem in Kenya, resistance to isoniazid and rifampicin MDR TB is less than previously estimated. The country should continue to monitor drug resistance and ensure effective use of anti TB medicines. 展开更多
关键词 Multi drug resistant TB Mycobacterium tuberculosis drug resistance Kenya.
下载PDF
肯尼亚、内罗毕涂阳肺结核的漏诊
3
作者 M.P.Hawken D.W.Muhindi +4 位作者 J.M.Chakaya S.M.Bhatt L.W.Ng'ang'a J.D.H.Porter 屠德华 《国际结核病与肺部疾病杂志》 2001年第2期71-73,共3页
背景:肯尼亚,内罗毕市委员会胸科诊所。 目的:为确定痰涂片漏读是造成肯尼亚内罗毕涂阴结核病不相称增加的因素。 方法:对1997年10月至1998年11月之间履行地方规划规定的认为是涂阴肺结核的病人,进一步收取两个痰标本,在研究实验室进行... 背景:肯尼亚,内罗毕市委员会胸科诊所。 目的:为确定痰涂片漏读是造成肯尼亚内罗毕涂阴结核病不相称增加的因素。 方法:对1997年10月至1998年11月之间履行地方规划规定的认为是涂阴肺结核的病人,进一步收取两个痰标本,在研究实验室进行萤光显微镜检查。 结果:在选入研究的163名成人病例中,55%为人类免疫缺陷病毒1型(HIV-1)血清学阳性,100名病人在收集和获得两次新的痰标本在研究实验室再检查之前,已有两个研究前的痰涂片检查。在这些人中,19名(19%)通过再次检查为痰涂片阳性和第二次再检查又有7名(7%)成为涂片阳性。 结论:由地方规划确定的认为是涂阴肺结核的病人中当仔细地两次重复痰涂片检查时有26%为涂片阳性,提示,在涂阴结核病中有高比例的漏读,这可能是由于结棱病负担太重而导致痰检查的过于迅速和欠精确。对固定技术人员的再培训和培训更多的技术人员可能减少漏读和增加涂阳结核病的检出。该发现也强调需要常规的质量保证。 展开更多
关键词 涂阴 结核病 HIV 低收入国家 非洲
下载PDF
Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya 被引量:2
4
作者 Beatrice Kirubi Jane Ong'angto +3 位作者 Peter Nguhiu Knut Lonnroth Aiban Rono Kristi Sidney-Annerstedt 《Infectious Diseases of Poverty》 SCIE 2021年第4期18-32,共15页
Background::Despite free diagnosis and treatment for tuberculosis(TB),the costs during treatment impose a significant financial burden on patients and their households.The study sought to identify the determinants for... Background::Despite free diagnosis and treatment for tuberculosis(TB),the costs during treatment impose a significant financial burden on patients and their households.The study sought to identify the determinants for cata-strophic costs among patients with drug-sensitive TB(DSTB)and their households in Kenya.Methods::The data was collected during the 2017 Kenya national patient cost survey from a nationally representative sample(n=1071).Treatment related costs and productivity losses were estimated.Total costs exceeding 20%of household income were defined as catastrophic and used as the outcome.Multivariable Poisson regression analysis was performed to measure the association between selected individual,household and disease characteristics and occurrence of catastrophic costs.A deterministic sensitivity analysis was carried using different thresholds and the significant predictors were explored.Results::The proportion of catastrophic costs among DSTB patients was 27%(n=294).Patients with catastrophic costs had higher median productivity losses,39 h[interquartile range(IQR):20-104],and total median costs of USD 567(IQR:299-1144).The incidence of catastrophic costs had a dose response with household expenditure.The poorest quintile was 6.2 times[95%confidence intervals(CI):4.0-9.7]more likely to incur catastrophic costs compared to the richest.The prevalence of catastrophic costs decreased with increasing household expenditure quintiles(proportion of catastrophic costs:59.7%,32.9%,23.6%,15.9%,and 9.5%)from the lowest quintile(Q1)to the highest quintile(Q5).Other determinants included hospitalization:prevalence ratio(PR)=2.8(95%CI:1.8-4.5)and delayed treatment:PR=1.5(95%CI:1.3-1.7).Protective factors included receiving care at a public health facility:PR=0.8(95%CI:0.6-1.0),and a higher body mass index(BMI):PR=0.97(95%CI:0.96-0.98).Pre TB expenditure,hospitalization and BMI were significant predictors in all sensitivity analysis scenarios.Conclusions::There are significant inequities in the occurrence of catastrophic costs.Social protection interventions in addition to existing medical and public health interventions are important to implement for patients most at risk of incurring catastrophic costs. 展开更多
关键词 TUBERCULOSIS Health expenditure Income loss Social protection Kenya
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部